Why PB28 Could Be a Covid 2019 Game Changer?-Reference-Cited by-同舟云学术

Why PB28 Could Be a Covid 2019 Game Changer?

Published:2020-08-14 Issue:10 Volume:11 Page:2048-2050
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Colabufo Nicola Antonio¹^ORCID,Leopoldo Marcello¹^ORCID,Ferorelli Savina¹,Abate Carmen¹^ORCID,Contino Marialessandra¹^ORCID,Perrone Maria Grazia¹,Niso Mauro¹,Perrone Roberto¹,Berardi Francesco¹

Affiliation:

1. Dipartimento Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4, 70125 Bari, Italy

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00271

Reference22 articles.

1. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

2. Chloroquine and hydroxychloroquine in the context of COVID-19

3. Hydroxychloroquine use in the COVID-19 patient

4. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The N,N,O-Trisubstituted Hydroxylamine Isostere and Its Influence on Lipophilicity and Related Parameters;ACS Medicinal Chemistry Letters;2022-04-20

2. Biophysical Evaluation and In Vitro Controlled Release of Two Isomeric Adamantane Phenylalkylamines with Antiproliferative/Anticancer and Analgesic Activity;Molecules;2021-12-21

3. Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy;Expert Opinion on Therapeutic Targets;2021-06-03

4. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective;Journal of Medicinal Chemistry;2021-06-02

5. PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships;Frontiers in Pharmacology;2020-12-07